Results 171 to 180 of about 92,782 (302)
Abstract Aims To evaluate whether faster insulin aspart (FIA) improves time in range (TIR) compared with standard insulin aspart (SIA) in children and adolescents with type 1 diabetes achieving glycaemia close to target treated with continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM).
Kowalczyk‐Korcz Emilia +3 more
wiley +1 more source
Gluten Catastrophe: A Fatal Case of Refractory Celiac Disease Type 2. [PDF]
Thakkar B +3 more
europepmc +1 more source
ABSTRACT Background Although international guidelines provide recommendations for screening and monitoring of early‐stage type 1 diabetes (T1D), navigating the care pathway can still be difficult for individuals, caregivers, and healthcare professionals (HCPs). These challenges are exacerbated by variations in healthcare systems, gaps in communication,
Chantal Mathieu +14 more
wiley +1 more source
When Is Celiac Disease Celiac Disease? [PDF]
Peter H R, Green, Stefano, Guandalini
openaire +2 more sources
Genetic risk variants in intestinal inflammatory disorders
PhDThis thesis includes work on the genetics of intestinal inflammatory disorders, concentrating on coeliac disease and Crohn’s disease. It explores how common genetic variants influence risk of complex phenotypes including immunological intolerance to
Dubois, Patrick Charles Alexander
core
ABSTRACT Introduction Type 1 diabetes (T1D) is a chronic autoimmune disease, characterised by progressive destruction of the insulin‐producing pancreatic β‐cells. Preserving remaining β‐cells at the time of diagnosis may improve long‐term outcomes. Frexalimab is a humanised monoclonal antibody specific for CD40L undergoing evaluation for treatment of ...
Andriy Cherkas +11 more
wiley +1 more source
Cocoa Attenuates Gluten-induced Pathogenesis in a Preclinical Model of Celiac Disease. [PDF]
Girbal-González M +6 more
europepmc +1 more source
Managing the pediatric patient with celiac disease: a multidisciplinary approach
Daniela Migliarese Isaac,1 Jessica Wu,2 Diana R Mager,3,4 Justine M Turner1 1Department of Pediatric Gastroenterology and Nutrition, Faculty of Medicine and Dentistry, University of Alberta; 2Alberta Health Services–Child Health Nutrition Services,
Wu J, Mager DR, Turner JM, Isaac DM
core
ABSTRACT Aims To test the hypothesis that continuous glucose monitoring (CGM) metrics are independently associated with cardiovascular risk factor (CVRF) exposure, particularly low‐density lipoprotein cholesterol (LDL‐C) and blood pressure (BP), in youth with type 1 diabetes (T1D) enrolled in the international SWEET registry. Materials and Methods This
Claudia Piona +13 more
wiley +1 more source

